Home/Eradivir/Martin Low

ML

Martin Low

Chief Executive Officer

Therapeutic Areas

Infectious Disease Oncology

Eradivir Pipeline

Drug	Indication	Phase
EV25	Influenza	Pre-clinical

Leadership Team at Eradivir

Philip S. Low, PhD

Chief Scientific Officer & Founder

Jeffery Nielsen, PhD

Chief Technology Officer

View full Eradivir profile